Area of research
Pulmonary and Respiratory Medicine · Physiology
Research interest
Research interests include Medicine, COPD, Asthma, Idiopathic pulmonary fibrosis, Immunology, and Internal medicine.
Tertiary lymphoid structures and B-cell infiltration are IPF features with functional consequences
Expression of human Interferon Regulatory Factor 3 (IRF-3) in alveolar macrophages relates to clinical and functional traits in COPD.
Prevalence of diaphragm dysfunction in patients with interstitial lung disease (ILD): The role of diaphragmatic ultrasound
The role of immune response in the pathogenesis of idiopathic pulmonary fibrosis: far beyond the Th1/Th2 imbalance
Characteristics and Prognostic Factors of Pulmonary Fibrosis After COVID-19 Pneumonia
Differences Between Early- and Late-Onset Asthma: Role of Comorbidities in Symptom Control
Critical Review of the Evolution of Extracellular Vesicles’ Knowledge: From 1946 to Today
Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment
Quantification and role of innate lymphoid cell subsets in Chronic Obstructive Pulmonary Disease
Pneumothorax and/or Pneumomediastinum Worsens the Prognosis of COVID-19 Patients with Severe Acute Respiratory Failure: A Multicenter Retrospective Case-Control Study in the North-East of Italy
Circulating Extracellular Vesicles Are Associated with Disease Severity and Interleukin-6 Levels in COPD: A Pilot Study
Air Pollution Exposure Impairs Airway Epithelium IFN-β Expression in Pre-School Children
Heart Failure is Highly Prevalent and Difficult to Diagnose in Severe Exacerbations of COPD Presenting to the Emergency Department
Clinical Features and Chest Imaging as Predictors of Intensity of Care in Patients with COVID-19
Microvesicles in bronchoalveolar lavage as a potential biomarker of COPD
Assessment of innate immunity mediators in the lung of COPD patients: relation with disease manifestations
The Role of the Lung’s Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis and Lung Transplantation: When it is Feasible
High-flow nasal cannula oxygen therapy to treat acute respiratory failure in patients with acute exacerbation of idiopathic pulmonary fibrosis
High-Resolution CT Change over Time in Patients with Idiopathic Pulmonary Fibrosis on Antifibrotic Treatment
Reassessing the Role of Eosinophils as a Biomarker in Chronic Obstructive Pulmonary Disease
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof‐of‐concept cohort study
Anti-inflammatory effects of roflumilast in chronic obstructive pulmonary disease (ROBERT): a 16-week, randomised, placebo-controlled trial
Clinical and Pathologic Factors Predicting Future Asthma in Wheezing Children. A Longitudinal Study
Looking for Airways Periostin in Severe Asthma
Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis
Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity
Blood Eosinophilia Neither Reflects Tissue Eosinophils nor Worsens Clinical Outcomes in Chronic Obstructive Pulmonary Disease
Deficient Immune Response to Viral Infections in Children Predicts Later Asthma Persistence
Severe asthma: phenotyping to endotyping or vice versa?